CPEX Pharmaceuticals
2 Holland Way
Exeter
New Hampshire
03833
United States
Tel: 603-658-6100
Fax: 603-658-6101
Website: http://www.cpexpharm.com/
49 articles about CPEX Pharmaceuticals
-
Footstar Completes Acquisition of CPEX Pharmaceuticals
4/6/2011
-
Mangrove Partners Notes CPEX Pharmaceuticals Stock Trading Above Offer Price
3/22/2011
-
CPEX Pharmaceuticals Advises Stockholders to Vote Today for the All-Cash, Premium FCB Transaction
3/22/2011
-
Mangrove Partners Expresses Disappointment in Board of CPEX Pharmaceuticals and Reaffirms Proposed Recapitalization and Intention to Vote Against Merger
3/21/2011
-
CPEX Pharmaceuticals Advises Stockholders to Take No Action at This Time in Response to Mangrove Partners’ Proposal
3/15/2011
-
ISS Proxy Advisory Services Recommends That CPEX Pharmaceuticals Stockholders Vote for Merger Agreement with FCB I Holdings
3/11/2011
-
CPEX Pharmaceuticals Sends Letter to Stockholders
3/3/2011
-
Mangrove Partners Questions the Proposed Sale of CPEX Pharmaceuticals and Intends to Vote 'No' on the Merger
2/28/2011
-
Footstar Announces Agreement To Acquire CPEX Pharmaceuticals in Transaction Valued at $76.6M
1/4/2011
-
CPEX Pharmaceuticals Announces Continuation of Strategic Alternatives Review Process; Company is Open to a Sale, Merger or Other Business Combination
9/29/2010
-
CPEX Pharmaceuticals Announces Continuation of Strategic Alternatives Review Process
9/29/2010
-
CPEX Pharmaceuticals Reports Second-Quarter 2010 Financial Results
8/9/2010
-
CPEX Pharmaceuticals Shareholders Elect Robert Forrester to Board of Directors
5/26/2010
-
CPEX Pharmaceuticals Says Hostile Bid by Investor Inadequate
5/6/2010
-
CPEX Pharmaceuticals Board of Directors Unanimously Recommends Shareholders Reject Tender Offer Announced by Richard Rofé
5/6/2010
-
CPEX Pharmaceuticals Reports First-Quarter 2010 Financial Results
5/5/2010
-
CPEX Pharmaceuticals Appoints Robert Forrester to Board of Directors
5/3/2010
-
CPEX Pharmaceuticals Advises Shareholders to Take No Action at This Time in Response to Arcadia Capital Advisors, LLC Unsolicited Tender Offer
4/26/2010
-
CPEX Pharmaceuticals Investor Makes Hostile Bid of $16/Share for Firm
4/23/2010
-
CPEX Pharmaceuticals Issues Open Letter to Shareholders
4/12/2010